It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Discovering anticancer drugs that do not have adverse side effects has been a developing research field worldwide in recent decades. In this work, four previously undescribed cytotoxic diterpenoids were isolated from the aerial parts of Isodon excisoides. Interestingly, these four diterpenoids were two pairs of tautomers that were first reported in plants. Their structures were further elucidated using various spectroscopic methods. The tautomerization phenomenon and mechanism for these two pairs of tautomers were emphatically described. The theoretical simulation results indicated that the diterpene tautomerization is greatly related to certain factors, including the existence of a transition state, the change of bond length and the level of conversion energy; the tautomerization for the two pairs of tautomers is mainly caused by proton transfer. For bioassays, the cytotoxicities of the tautomers against five human cancer cell lines were also investigated. The results indicated that each of the four diterpenoids showed significant cytotoxicity in at least three cell lines and could serve as potential anticancer agents for further investigation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Henan University of Traditional Chinese Medicine, School of Pharmacy, Zhengzhou, China (GRID:grid.412098.6) (ISNI:0000 0000 9277 8602); Henan University of Traditional Chinese Medicine, Research Center for Classic Chinese Medicines & Health Herbal Products, Zhengzhou, China (GRID:grid.412098.6) (ISNI:0000 0000 9277 8602)
2 Henan University of Traditional Chinese Medicine, School of Pharmacy, Zhengzhou, China (GRID:grid.412098.6) (ISNI:0000 0000 9277 8602)
3 Henan University of Traditional Chinese Medicine, Research Center for Classic Chinese Medicines & Health Herbal Products, Zhengzhou, China (GRID:grid.412098.6) (ISNI:0000 0000 9277 8602)
4 The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan, China (GRID:grid.412098.6)
5 Henan University of Traditional Chinese Medicine, Research Center for Classic Chinese Medicines & Health Herbal Products, Zhengzhou, China (GRID:grid.412098.6) (ISNI:0000 0000 9277 8602); China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, China (GRID:grid.410318.f) (ISNI:0000 0004 0632 3409)